Guidelines & Consensus
WHO 6th Edition Gastric Carcinoma Classification
KushimaVirchows Archiv
The sixth edition of the WHO Classification of Digestive System Tumours (2026) updates the diagnostic framework for gastric carcinoma by combining traditional morphology with advances in molecular pathology, genotype–phenotype correlations, and predictive biomarker evaluation. Although core histological categories remain intact, several key refinements have been implemented, including the recognition of crawling-type adenocarcinoma as a variant of tubular adenocarcinoma, subclassification of poorly cohesive carcinoma into signet-ring cell and non-signet-ring cell subtypes, and introduction of pure signet-ring cell carcinoma. The guidelines also update definitions for uncommon entities such as gastric carcinoma with lymphoid stroma, AFP-producing carcinoma, micropapillary adenocarcinoma, gastric adenocarcinoma of fundic-gland type, and gastric sarcomatoid carcinoma. Crucially, molecular subgroups established by The Cancer Genome Atlas (TCGA) and actionable biomarkers—such as HER2 (ERBB2), Claudin 18.2, mismatch repair deficiency/microsatellite instability (dMMR/MSI), and PD-L1—have transitioned into essential tools for pathological diagnosis, prognostication, and therapeutic stratification.
Key Takeaways
- The WHO 6th edition introduces specific histological refinements to gastric carcinoma, recognizing crawling-type adenocarcinoma as a tubular variant and subclassifying poorly cohesive carcinoma into signet-ring cell and non-signet-ring cell subtypes along with pure signet-ring cell carcinoma.
- TCGA molecular subgroups and actionable biomarkers—including HER2, Claudin 18.2, dMMR/MSI, and PD-L1—are formally integrated into the diagnostic framework as essential clinical tools for precision oncology and therapeutic stratification.
- The updated classification expands diagnostic criteria for uncommon gastric carcinoma subtypes, including gastric adenocarcinoma of fundic-gland type, micropapillary adenocarcinoma, AFP-producing carcinoma, gastric sarcomatoid carcinoma, and gastric carcinoma with lymphoid stroma.
Read the original sourceVirchows Archiv
